...Burton & Co. and the Montreal-based Centre for Commercialization of Cancer Immunotherapy (C3i). Oceanpine Capital and Viva Biotech...

...has raised tens of millions in an A+ round from Shenzhen Capital Group. Incubated by Viva Biotech...

...Cobro Ventures and Taiwania Capital Management Corp., with participation from 3E Bioventures Capital, Yonjin Capital, Viva Biotech...

...NASDAQ:NXTC) 5/8/19 $86.3 $340.3 $340.3 0% Axcella Health Inc. (NASDAQ:AXLA) 5/8/19 $71.4 $459.8 $214.2 -53% Viva Biotech...

...it ended the week down 17% from its listing price. Meanwhile in Hong Kong, CRO Viva Biotech...

...in an IPO that values the drug discovery services company at HK$6.6 billion (US$843.1 million). Viva Biotech...
...Biopharm Co. Ltd. (Suzhou, China). -Assistant Editor Paul Bonanos contributed to this report. Hongjiang Li, Staff Writer Viva Biotech...

...prices its Hong Kong IPO at the midpoint of the range it proposed April 25. Viva Biotech...
...the Hong Kong stock exchange. The company proposed the listing in July 2018 (see "CRO Viva Biotech...
...lapse (see "Ascentage Hops in Hong Kong IPO Queue" ). Hongjiang Li, Staff Writer Ascentage Pharma Group International Viva Biotech...

...HKEX) 8/22/18 TBD Ph III (biosimilar) Ascentage Pharma Group International (HKEX) 8/20/18 TBD Ph II/III Viva Biotech...

...time of filing; Source: BCIQ: BioCentury Online Intelligence, HKEX website Company Date filed Status (A) Viva Biotech...

...in exchange for 10% to 30% equity in an equity-for-service model. Viva Biotech Holdings, Shanghai, China Alicia Parker Viva Biotech...